Literature DB >> 9227318

Differential expression of CD32 isoforms following alloactivation of human T cells.

G P Sandilands1, S A MacPherson, E R Burnett, A J Russell, I Downie, R N MacSween.   

Abstract

Receptors for the Fc region of immunoglobulin G (IgG) (Fc gamma Rs) exist in three main forms: membrane bound, soluble and cytoplasmic. The function of cytoplasmic Fc gamma Rs is poorly understood. We have previously demonstrated cytoplasmic Fc gamma RII (cCD32) within most normal human peripheral blood lymphocytes (PBL), including T cells. In this study we have investigated the hypothesis that following lymphocyte activation, up-regulation of cCD32 occurs, resulting in increased expression at the cell surface. Normal PBL were activated in vitro using a two-way mixed lymphocyte reaction (MLR) and expression of CD32 monitored by flow cytometry and by immunoperoxidase staining using specific monoclonal antibodies and aggregated mouse IgG subclasses. Furthermore, we designed oligonucleotide probes specific for the three main isoforms of CD32 and looked for changes in mRNA expression throughout the MLR using an in situ hybridization technique. Increased surface expression of CD32 was found on both activated human T and B lymphocytes, but this was found only in the early stages of the MLR, on days 3 and 4, and was virtually absent by day 7. An inverse relationship between cell surface expression of CD32 and mRNA for the IIb isoforms was noted with strong mRNA expression for IIb isoforms occurring in the later stages of the MLR (days 6-7) when interleukin-2R (IL-2R)-positive T cells were predominant. A soluble IgG binding factor (soluble CD32?) was also detected in the MLR culture supernatant. These observations provide support for the hypothesis that synthesis of IIb isoforms of CD32 occurs following alloantigen activation of human T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227318      PMCID: PMC1363848          DOI: 10.1046/j.1365-2567.1997.00241.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

Review 1.  Structural bases of Fc gamma receptor functions.

Authors:  W H Fridman; C Bonnerot; M Daeron; S Amigorena; J L Teillaud; C Sautes
Journal:  Immunol Rev       Date:  1992-02       Impact factor: 12.988

Review 2.  Biology of human immunoglobulin G Fc receptors.

Authors:  J G van de Winkel; C L Anderson
Journal:  J Leukoc Biol       Date:  1991-05       Impact factor: 4.962

Review 3.  Fc receptors.

Authors:  J V Ravetch; J P Kinet
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

4.  On the origin of the FcRIII (CD16)-containing vesicle population in human neutrophil granulocytes.

Authors:  C R Jost; R de Goede; J A Fransen; M R Daha; L A Ginsel
Journal:  Eur J Cell Biol       Date:  1991-04       Impact factor: 4.492

5.  Occult expression of CD32 (Fc gamma RII) in normal human peripheral blood mononuclear cells.

Authors:  G P Sandilands; A P McLaren; D Howie; R N MacSween
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

6.  CD32A (Fc gamma RIIa) mRNA expression and regulation in blood monocytes and cell lines.

Authors:  Y G Alevy; J Tucker; T Mohanakumar
Journal:  Mol Immunol       Date:  1992-11       Impact factor: 4.407

7.  Detection of messenger RNA using a digoxigenin end labelled oligodeoxynucleotide probe.

Authors:  M Farquharson; R Harvie; A M McNicol
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

8.  Internalization and rapid recycling of macrophage Fc receptors tagged with monovalent antireceptor antibody: possible role of a prelysosomal compartment.

Authors:  I Mellman; H Plutner; P Ukkonen
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

9.  Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes.

Authors:  D G Brooks; W Q Qiu; A D Luster; J V Ravetch
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

10.  Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).

Authors:  L L Lanier; T J Kipps; J H Phillips
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  9 in total

1.  B-cell antigens within normal and activated human T cells.

Authors:  G P Sandilands; M Perry; M Wootton; J Hair; I A More
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

2.  Evidence that CD32a does not mark the HIV-1 latent reservoir.

Authors:  Christa E Osuna; So-Yon Lim; Jessica L Kublin; Richard Apps; Elsa Chen; Talia M Mota; Szu-Han Huang; Yanqin Ren; Nathaniel D Bachtel; Athe M Tsibris; Margaret E Ackerman; R Brad Jones; Douglas F Nixon; James B Whitney
Journal:  Nature       Date:  2018-09-19       Impact factor: 49.962

3.  CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.

Authors:  Mohamed Abdel-Mohsen; Leticia Kuri-Cervantes; Judith Grau-Exposito; Adam M Spivak; Racheal A Nell; Costin Tomescu; Surya Kumari Vadrevu; Leila B Giron; Carla Serra-Peinado; Meritxell Genescà; Josep Castellví; Guoxin Wu; Perla M Del Rio Estrada; Mauricio González-Navarro; Kenneth Lynn; Colin T King; Sai Vemula; Kara Cox; Yanmin Wan; Qingsheng Li; Karam Mounzer; Jay Kostman; Ian Frank; Mirko Paiardini; Daria Hazuda; Gustavo Reyes-Terán; Douglas Richman; Bonnie Howell; Pablo Tebas; Javier Martinez-Picado; Vicente Planelles; Maria J Buzon; Michael R Betts; Luis J Montaner
Journal:  Sci Transl Med       Date:  2018-04-18       Impact factor: 17.956

4.  IgG Fc variant cross-reactivity between human and rhesus macaque FcγRs.

Authors:  Austin W Boesch; Adam R Miles; Ying N Chan; Nana Y Osei-Owusu; Margaret E Ackerman
Journal:  MAbs       Date:  2017-01-05       Impact factor: 5.857

5.  Phenotypic differences between healthy effector CTL and leukemic LGL cells support the notion of antigen-triggered clonal transformation in T-LGL leukemia.

Authors:  Marcin W Wlodarski; Zachary Nearman; Anna Jankowska; Nina Babel; Jennifer Powers; Patrick Leahy; Hans-Dieter Volk; Jaroslaw P Maciejewski
Journal:  J Leukoc Biol       Date:  2007-12-17       Impact factor: 4.962

6.  CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA.

Authors:  Genevieve E Martin; Matthew Pace; John P Thornhill; Chansavath Phetsouphanh; Jodi Meyerowitz; Morgane Gossez; Helen Brown; Natalia Olejniczak; Julianne Lwanga; Gita Ramjee; Pontiano Kaleebu; Kholoud Porter; Christian B Willberg; Paul Klenerman; Nneka Nwokolo; Julie Fox; Sarah Fidler; John Frater
Journal:  Front Immunol       Date:  2018-05-04       Impact factor: 7.561

7.  CD32-RNA Co-localizes with HIV-RNA in CD3+ Cells Found within Gut Tissues from Viremic and ART-Suppressed Individuals.

Authors:  Joshua J Vásquez; Brandon L Aguilar-Rodriguez; Leonardo Rodriguez; Louise E Hogan; Ma Somsouk; Joseph M McCune; Steven G Deeks; Zoltan G Laszik; Peter W Hunt; Timothy J Henrich
Journal:  Pathog Immun       Date:  2019-05-03

8.  CD32 Ligation Promotes the Activation of CD4+ T Cells.

Authors:  María Pía Holgado; Inés Sananez; Silvina Raiden; Jorge R Geffner; Lourdes Arruvito
Journal:  Front Immunol       Date:  2018-11-30       Impact factor: 7.561

9.  CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control.

Authors:  Marcial García; María Angeles Navarrete-Muñoz; José M Ligos; Alfonso Cabello; Clara Restrepo; Juan Carlos López-Bernaldo; Francisco Javier de la Hera; Carlos Barros; María Montoya; Manuel Fernández-Guerrero; Vicente Estrada; Miguel Górgolas; José M Benito; Norma Rallón
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.